Cell-type-resolved methylation analysis using bulk long-read sequencing across human tissues

DNA methylation shapes cellular identity and changes with aging and disease, but most human methylomes come from bulk tissue, which mixes signal across many cell types. A methylation change at the bulk tissue level can reflect a change in cellular composition or an intrinsic shift within a cell type, and the two cannot be separated from bulk data. Single-cell and sorted-cell methods resolve cell types directly, but their cost and workflow complexity pose challenges to large studies. Long-read sequencing of single DNA molecules can directly detect DNA methylation on each read. We built COMET (Cell-of-Origin from METhylation), a framework that uses cell-type-specific methylation to assign individual long reads to cell types from standard bulk long-read sequencing. COMET detects changes in cell-type composition robustly even from shallow bulk long-read data, quantifies methylation level of repetitive DNA within each cell type, and, with deeper sequencing, resolves methylation differences between health and disease in individual cell types. We applied COMET to 140 human blood samples, 104 human brain samples and 59 human colon samples. In blood, we found epigenetic aging clock is primarily driven by shifts in cell-type composition, and that APOE4 carriers have myeloid-specific methylation changes. In brain, we found sex-biased change in cell-type composition with age, resolved methylation and hydroxymethylation separately within each cell type. In colon, we found a consistent expansion of fibroblasts in tumors relative to matched normal tissue, localized methylation loss at LINE-1 in fibroblast cells, and identified tumor- and cell-type-specific hypermethylation in epithelial cells at the promoters of known colorectal cancer genes. By resolving cell-type-specific methylation directly from bulk long-read data, this approach opens broad study of cell-type epigenetics across human tissues in aging and disease.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-19
DOI
https://doi.org/10.64898/2026.11.18.767445
Primary Topic
Epigenetics and DNA Methylation
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Cell-type-resolved methylation analysis using bulk long-read sequencing across human tissues

Rahul M. Kohli, Mi Ni, Jamshid Abdul‐Ghafar, Jan Vijg et al.
bioRxiv (Cold Spring Harbor Laboratory)
Epigenetics and DNA Methylation
preprint

Cell-type-resolved methylation analysis using bulk long-read sequencing across human tissues

Rahul M. Kohli, Mi Ni, Jamshid Abdul‐Ghafar, Jan Vijg, Casidhe-Nicole R. Bethancourt, Salima Soualhi, Zi Yan, Kurt W. Farrell, Stella M. Dracheva, Emma L Thorn, ZHANG Yanchun, Louis J. Cohen, Deirdre Jill Cohen, Edward A. Mead, Alexey Kozlenkov, Joel T. Gabre, John F. Crary, Eric E. Bouhassira, Gang Fang, Ernesto Guccione, Rachel Brody, Nikolaos Karvelas, Fanny M. Elahi, Slim Mzoughi, Alexander W. Charney, David A. Cohen, Gordon Fan-Huang, Yu Fan, Zhangying Chen, Hao Wu, Hao Chen
preprint en

Abstract

DNA methylation shapes cellular identity and changes with aging and disease, but most human methylomes come from bulk tissue, which mixes signal across many cell types. A methylation change at the bulk tissue level can reflect a change in cellular composition or an intrinsic shift within a cell type, and the two cannot be separated from bulk data. Single-cell and sorted-cell methods resolve cell types directly, but their cost and workflow complexity pose challenges to large studies. Long-read sequencing of single DNA molecules can directly detect DNA methylation on each read. We built COMET (Cell-of-Origin from METhylation), a framework that uses cell-type-specific methylation to assign individual long reads to cell types from standard bulk long-read sequencing. COMET detects changes in cell-type composition robustly even from shallow bulk long-read data, quantifies methylation level of repetitive DNA within each cell type, and, with deeper sequencing, resolves methylation differences between health and disease in individual cell types. We applied COMET to 140 human blood samples, 104 human brain samples and 59 human colon samples. In blood, we found epigenetic aging clock is primarily driven by shifts in cell-type composition, and that APOE4 carriers have myeloid-specific methylation changes. In brain, we found sex-biased change in cell-type composition with age, resolved methylation and hydroxymethylation separately within each cell type. In colon, we found a consistent expansion of fibroblasts in tumors relative to matched normal tissue, localized methylation loss at LINE-1 in fibroblast cells, and identified tumor- and cell-type-specific hypermethylation in epithelial cells at the promoters of known colorectal cancer genes. By resolving cell-type-specific methylation directly from bulk long-read data, this approach opens broad study of cell-type epigenetics across human tissues in aging and disease.

bioRxiv (Cold Spring Harbor Laboratory)
Albert Einstein College of Medicine (US), Columbia University Irving Medical Center (US), University of Pennsylvania (US), Icahn School of Medicine at Mount Sinai (US)
Epigenetics and DNA Methylation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon